These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 33038984)
21. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959 [TBL] [Abstract][Full Text] [Related]
22. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review. Fontana D; Elli EM; Pagni F; Piazza R Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785 [TBL] [Abstract][Full Text] [Related]
23. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970 [TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future. Nathan DI; Feld J; El Jamal SM; Mascarenhas J; Tremblay D Leuk Res; 2022 Apr; 115():106820. PubMed ID: 35279478 [TBL] [Abstract][Full Text] [Related]
25. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy. Loh ML; Mullighan CG Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484 [TBL] [Abstract][Full Text] [Related]
26. Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature. Wintering A; Smith S; Fuh B; Rangaswami A; Dahl G; Chien M; Gruber TA; Dang J; Li LS; Lenzen A; Savelli S; Dvorak CC; Agrawal AK; Stieglitz E Pediatr Blood Cancer; 2022 May; 69(5):e29499. PubMed ID: 34939322 [TBL] [Abstract][Full Text] [Related]
27. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management". Patnaik MM; Tefferi A Am J Hematol; 2021 Mar; 96(3):379-394. PubMed ID: 33428785 [TBL] [Abstract][Full Text] [Related]
28. Current and evolving understanding of atypical chronic myeloid leukemia. Schwartz LC; Mascarenhas J Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497 [TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic/myeloproliferative neoplasms - Justified inclusion as unique biological entities. Patnaik MM Best Pract Res Clin Haematol; 2020 Jun; 33(2):101135. PubMed ID: 32460978 [No Abstract] [Full Text] [Related]
30. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934 [TBL] [Abstract][Full Text] [Related]
31. MDS/MPN-RS-T justified inclusion as a unique disease entity? Montalban-Bravo G; Garcia-Manero G Best Pract Res Clin Haematol; 2020 Jun; 33(2):101147. PubMed ID: 32460979 [TBL] [Abstract][Full Text] [Related]
32. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management". Patnaik MM; Tefferi A Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061 [TBL] [Abstract][Full Text] [Related]
33. Peculiarities in the Diagnosis Approach of MDS /MPN-U Patients. Triantafyllidis I; Ciobanu A; Stanca O; Draghici C; Angelescu S; Tapelea E Maedica (Bucur); 2012 Jun; 7(2):173-6. PubMed ID: 23401728 [TBL] [Abstract][Full Text] [Related]
34. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. Szuber N; Orazi A; Tefferi A Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693 [TBL] [Abstract][Full Text] [Related]
35. I walk the other line: myelodysplastic/myeloproliferative neoplasm overlap syndromes. Gerds AT Curr Hematol Malig Rep; 2014 Dec; 9(4):400-6. PubMed ID: 25195196 [TBL] [Abstract][Full Text] [Related]